Authors:
Hidalgo, M
Siu, LL
Nemunaitis, J
Rizzo, J
Hammond, LA
Takimoto, C
Eckhardt, SG
Tolcher, A
Britten, CD
Denis, L
Ferrante, K
Von Hoff, DD
Silberman, S
Rowinsky, EK
Citation: M. Hidalgo et al., Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies, J CL ONCOL, 19(13), 2001, pp. 3267-3279